Guggenheim Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1M | Sell |
|
|||||
|
2025
Q1 | $49.5M | Sell |
|
|||||
|
2024
Q4 | $54.6M | Sell |
|
|||||
|
2024
Q3 | $64.8M | Sell |
|
|||||
|
2024
Q2 | $74.8M | Sell |
|
|||||
|
2024
Q1 | $69.3M | Sell |
|
|||||
|
2023
Q4 | $69.8M | Buy |
|
|||||
|
2023
Q3 | $56.3M | Buy |
|
|||||
|
2023
Q2 | $55.9M | Sell |
|
|||||
|
2023
Q1 | $51.3M | Sell |
|
|||||
|
2022
Q4 | $48.8M | Sell |
|
|||||
|
2022
Q3 | $50.7M | Sell |
|
|||||
|
2022
Q2 | $55M | Sell |
|
|||||
|
2022
Q1 | $57.6M | Buy |
|
|||||
|
2021
Q4 | $46.5M | Buy |
|
|||||
|
2021
Q3 | $37.6M | Sell |
|
|||||
|
2021
Q2 | $43.6M | Buy |
|
|||||
|
2021
Q1 | $43.8M | Sell |
|
|||||
|
2020
Q4 | $49.6M | Buy |
|
|||||
|
2020
Q3 | $52.3M | Sell |
|
|||||
|
2020
Q2 | $56.7M | Buy |
|
|||||
|
2020
Q1 | $45.6M | Sell |
|
|||||
|
2019
Q4 | $46.7M | Sell |
|
|||||
|
2019
Q3 | $39.6M | Sell |
|
|||||
|
2019
Q2 | $43.3M | Sell |
|
|||||
|
2019
Q1 | $45.4M | Buy |
|
|||||
|
2018
Q4 | $38.9M | Sell |
|
|||||
|
2018
Q3 | $50M | Sell |
|
|||||
|
2018
Q2 | $44.6M | Sell |
|
|||||
|
2018
Q1 | $120M | Sell |
|
|||||
|
2017
Q4 | $121M | Buy |
|
|||||
|
2017
Q3 | $65.2M | Sell |
|
|||||
|
2017
Q2 | $64.1M | Sell |
|
|||||
|
2017
Q1 | $62.4M | Sell |
|
|||||
|
2016
Q4 | $45.3M | Buy |
|
|||||
|
2016
Q3 | $43.7M | Sell |
|
|||||
|
2016
Q2 | $43.3M | Sell |
|
|||||
|
2016
Q1 | $41.1M | Buy |
|
|||||
|
2015
Q4 | $63.6M | Sell |
|
|||||
|
2015
Q3 | $53.4M | Sell |
|
|||||
|
2015
Q2 | $78.4M | Buy |
|
|||||
|
2015
Q1 | $71.5M | Buy |
|
|||||
|
2014
Q4 | $61.2M | Sell |
|
|||||
|
2014
Q3 | $103M | Buy |
|
|||||
|
2014
Q2 | $83.7M | Sell |
|
|||||
|
2014
Q1 | $66.5M | Buy |
|
|||||
|
2013
Q4 | $56.3M | Buy |
|
|||||
|
2013
Q3 | $52.4M | Buy |
|
|||||
|
2013
Q2 | $44.1M | Buy |
|